Fig 5. Tanshinol reduced OVX-elevated the markers of bone turnover.
Rats underwent OVX surgery, tanshinol or E2 treatment, and then the contents of (A) serum and (B) bone-specific ALP, (C) OCN and (D) TRACP-5b in rats were measured by using commercial kits. OVX, ovariectomized; E2, β-estradiol; ALP, alkaline phosphatase; OCN, osteocalcin; TRACP-5b, Tartrate-resistant acid phosphatase-5b. n = 3. *, P < 0.05.